Publications

Publications

Filter Results: (10) Arrow Down

Show Results For

Page 1 of 10 Results
Sort by

Are you looking for?

→Search All HBS Web
  • October 2012
  • Teaching Plan

Vertex Pharmaceuticals and the Cystic Fibrosis Foundation: Venture Philanthropy Funding for Biotech (TP)

By: Robert F. Higgins
This is the teaching note related to HBS case 808005. In 2001, Vertex Pharmaceuticals Incorporated acquired the San Diego-based biotech company, Aurora Biosciences. The combination of Vertex's and Aurora's technologies would improve the flow of novel drug candidates... View Details
Keywords: Venture Philanthropy; Biotechnology; Funding Philanthropy Venture; Cystic Fibrosis; Foundations; Pharmaceuticals; Mergers and Acquisitions; For-Profit Firms; Venture Capital; Philanthropy and Charitable Giving; Science-Based Business; Nonprofit Organizations; Pharmaceutical Industry; Biotechnology Industry; United States; San Diego
Related
  • April 2009 (Revised October 2010)
  • Case

Bob Beall at the Cystic Fibrosis Foundation

By: Robert Steven Kaplan and Sophie Hood
Bob Beall is the Chief Executive Officer of the Cystic Fibrosis Foundation (CFF). CFF is an extremely successful organization, but Beall has to determine how to manage the organization through the financial crisis of 2008-2009. In this situation, donations are likely... View Details
Keywords: Decision Choices and Conditions; Financial Crisis; Philanthropy and Charitable Giving; Governing and Advisory Boards; Leadership; Crisis Management; Nonprofit Organizations
Related
  • March 2010 (Revised June 2011)
  • Teaching Note

Bob Beall at the Cystic Fibrosis Foundation (TN)

By: Robert Steven Kaplan
Teaching Note for 409107. View Details
Keywords: Health Industry
Related
  • October 2007 (Revised July 2013)
  • Case

Vertex Pharmaceuticals and the Cystic Fibrosis Foundation: Venture Philanthropy Funding for Biotech

By: Robert F. Higgins, Sophie LaMontagne and Brent Kazan
In 2001, Vertex Pharmaceuticals Incorporated acquired the San Diego-based biotech company, Aurora Biosciences. The combination of Vertex's and Aurora's technologies would improve the flow of novel drug candidates into development. However, several questions related to... View Details
Keywords: Philanthropy; Philanthropy Funding; Innovation; Funding Model; Venture Capital; Partners and Partnerships; Financing and Loans; Investment Funds; Acquisition; Philanthropy and Charitable Giving; Biotechnology Industry; Pharmaceutical Industry; San Diego
Related
  • November 2023 (Revised April 2024)
  • Case

BiomX: Bringing Phage Back to the Stage

By: Paul A. Gompers, Elie Ofek, Orna Dan and Emilie Billaud
In the spring of 2023, and following the favorable results of a trial involving its phage cocktail for treating lung infections among cystic fibrosis (CF) patients, the leadership of BiomX had several critical issues to wrestle with. First, given its precarious... View Details
Keywords: Working Capital; Financing and Loans; Health Testing and Trials; Product Development; Research and Development; Science-Based Business; Commercialization; Biotechnology Industry; Pharmaceutical Industry
Related
  • 05 Jun 2006
  • Research & Ideas

Using Competition to Reform Healthcare

a disadvantage. Strategic focus is not about narrow specialization, but the pursuit of excellence and deepening penetration in the chosen fields. At Fairview-University Children's Hospital (Minnesota), for example, a long-term commitment to excellence in the area of... View Details
Keywords: by Michael E. Porter; Health
  • 28 Jun 2010
  • HBS Case

Cincinnati Children’s Hospital Medical Center

implementing a "forcing function" into the operating room process that keeps patients out of the OR until they've received antibiotics, thus reducing surgical site infections. For another project, she selects the hospital's View Details
Keywords: by Julia Hanna; Health
  • 06 May 2008
  • First Look

First Look: May 6, 2008

candidates into development. However, several questions related to the integration of Aurora into Vertex were still unresolved, the most pressing being Aurora's major collaboration with the Cystic Fibrosis... View Details
Keywords: Martha Lagace
  • 15 Jan 2018
  • Research & Ideas

A Better Business Model for Fighting Cancer

The Kraft team is conducting interviews to evaluate models at the Cystic Fibrosis Foundation (philanthropy); at Stanford’s StartX and MIT’s Sandbox (incubator); and at Breakout Labs and Root Capital (venture... View Details
Keywords: by Julia Hanna; Health; Pharmaceutical
  • 12 May 2009
  • First Look

First Look: May 12, 2009

the Cystic Fibrosis Foundation Harvard Business School Case 409-107 Bob Beall is the Chief Executive Officer of the Cystic Fibrosis Foundation... View Details
Keywords: Martha Lagace

Are you looking for?

→Search All HBS Web